Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Recruiting

Phase 3

Pump Chemotherapy vs. Standard of CareTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Sponsor:

ECOG-ACRIN Cancer Research Group

Code:

NCT05863195

Conditions

Metastatic Colorectal Carcinoma

Metastatic Malignant Neoplasm in the Liver

Stage IV Colorectal Cancer AJCC v8

Unresectable Colorectal Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Cetuximab

Computed Tomography

Floxuridine

Fluorouracil

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-15. This information was provided to ClinicalTrials.gov by ECOG-ACRIN Cancer Research Group on 2024-11-05.